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Case report
A 56-year-old Caribbean-American 
man presented with a 10-year history of 
intermittent left thigh swelling. He had a 
past medical history of  renal transplant, 
diabetes, gout, and hyperlipidemia. 
The patient grew up in the Virgin 
Islands, and at the age of  17 years, he 
had a misadventure climbing a mango 
tree. A branch broke, sending him 
earthward, and his left thigh was im-
paled on a 6-cm branch. He dangled for 
an hour and a half  before being extri-
cated. He was treated in a local hospital 
for at least a month, but there was no 
surgical exploration. He underwent a 
renal transplant at the age of  52, in 
2004, and since that time he suffered 
intermittent swelling and discomfort in 
his left thigh. The most recent episode of 
this occurred in May or early June of  2008, when he no-
ticed a marked increase in swelling and pain. He went to 
the emergency room, and was given some Bactrim. A few 
days later, on examination, the patient had a temperature 
of  100 F. His left thigh had a fullness in the lateral aspect, 
although it was not tender to palpation and there was no 
erythema. Laboratory findings were unremarkable with a 
white blood cell (WBC) count of  5.45K/uL (normal 4.3–
10.0). At that time, a CT scan showed a 6 x 4 x 2 enhanc-
ing abscess cavity in the left anterior thigh with extension to 
deep structures (Fig. 1).
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Phaeoacremonium parasiticum is an unusual cause of  human fungal infection that was first reported in 1974. 
Since the initial description, only a small number of  cases have been reported in the world literature. We 
report on the clinical and imaging findings of  Phaeoacremonium parasiticum myositis in a renal transplant 
recipient. To our understanding, this is a first case report of  Phaeoacremonium parasiticum myositis that in-
cludes imaging findings.
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Figure 1. 56-year-old man with Phaeoacremonium parasiticum myositis. Axial CT 
of the left thigh with intravenous contrast. A. In the soft tissues of the lateral thigh, 
a 5.6 x 4.4 x 1.5-centimeter rim-enhancing abscess tracking appears between the 
iliotibial band and the underlying anterior compartment musculature (arrows). B. 
Note the deep extension into the underlying vastus lateralis (arrowheads).
He was taken to the operating room for irrigation and 
debridement, and two abscess cavities were opened. At that 
time, a small foreign body was removed (Fig. 2). It was later 
identified as a piece of  wood. 
Following discharge from the hospital, he took oral levo-
floxacin for a couple of  weeks. Fungal cultures from the 
operative specimens were positive, and definitively identi-
fied as Phaeoacremonium parasiticum by DNA sequence analy-
sis. Antifungal treatment was begun with posaconazole 
(Noxafil). Followup MRIs were performed at 3, 6, and 9 
months after the initiation of  posaconazole treatment (Figs. 
3-4).
There was a nodular, somewhat serpinginous focus of  
enhancement within the vastus lateralis muscle that pre-
sumably represented infected granulation tissue on 3-
month followup MRI. Enhancing edema appeared in the 
surrounding vastus lateralis without rim-enhancing abscess. 
The contrast enhancement and edema in the vastus later-
alis muscle and a conglomerated enhancing lesion had de-
creased in size on 9-month followup. On physical exam at 9 
months followup, the patient had slight tenderness at the 
thigh but no fevers, chills, streaking, redness, or regional 
adenopathy.
Discussion
This is the first reported observation of  fungal myositis 
caused by Phaeoacremonium parasiticum, an unusual cause of  
human fungal infections. It was first reported in 1974 as 
Phialophora parasitica, causing subcutaneous tissue infection 
in a renal-transplant recipient (1). In 1996, a new hypho-
mycete genus, Phaeoacremonium, was proposed for six new 
species, including the type species, P. parasiticum, which was 
formerly accommodated in Phialophora (2). Presently, the 
Phaeoacremonium genus includes 22 species (3). Phaeoacremo-
nium is a genus of  dematiaceous hyphomycetes (dark-
pigmented fungi) characterized by the presence of  melanin 
or melanin-like pigments in their vegetative cell walls, co-
nidia, or both. These saprophytic fungi are widely distrib-
uted in the environment, particularly in soil, wood, and 
other plant matter.
Infections caused by dematiaceous fungi include eumy-
cotic mycetoma, chromoblastomycosis, and phaeohypho-
mycosis. The formation of  granules in tissue is diagnostic of 
mycetoma. The formation of  sclerotic bodies is the diag-
nostic hallmark of  chromoblastomycosis. Phaeohyphomy-
cosis comprises a heterogeneous group of  infections that 
range from superficial, cutaneous, and subcutaneous to 
systemic and are caused by more than 100 species of  di-
verse dematiaceous fungi. In their invasive form in host 
tissue, these fungi develop as phaeoid yeastlike cells, hyphal 
elements, pseudohyphael elements, moniliform hyphae, or 
a combination of  any of  these forms (4).
Fungal infections in solid-organ-transplant patients are a 
major concern due to their associated morbidity and mor-
tality. The prevalence of  this problem ranges from 5% 
among kidney transplants to 50% among liver transplants. 
The outcome of  fungal infection in solid-organ transplanta-
tion also varies by type of  organ transplant (5). Candida and 
Aspergillus have been common fungal pathogens in the solid-
organ-transplant population; however, the dematiaceous 
fungi are increasingly recognized in this immunocompro-
mised patient population (6). Singh et al. reviewed 34 cases 
of  dematiaceous fungal infections in solid organ transplant 
recipients (7). Not like commonly observed fungal infections  
after transplantation (for example, candidiasis and aspergil-
losis), which usually occur early (within 3 months of  trans-
plantation) and present predominantly as systemic invasive 
infections, infections due to dematiaceous fungi occurred 
late and presented most frequently as skin and/or soft-
tissue infections. Environmental or accidental trauma pre-
ceded such lesions in 48% of  the cases. The lesions were 
usually painless, had indolent courses, and smoldered for 
weeks to months before being brought to the attention of  a 
physician.
Phaeoacremonium species are mainly found in the soil, in 
woody plants as endophytes, or as agents of  plant disease 
(8). The spectrum of  disease caused by P. parasiticum in-
cludes subcutaneous infection (1, 9), eumycetoma (10), ar-
thritis (11), osteomyelitis (12), and disseminated disease in-
cluding fungemia, endocarditis, and cases with multiorgan 
involvement (13-15). Most reported Phaeoacremonium cases 
were initiated by traumatic inoculation (16). However, in 
many reported cases, no known trauma occurred (9, 12). Of 
cases reported to date, many involve immunocompromised 
patients who are organtransplant recipients (1, 9, 14, 17). It 
is striking that many case reports involved renal-transplant 
patients with subcutaneous and/or joint infections, mostly 
involving the leg (1, 9, 17).
Fungal involvement of  the musculature is uncommon but 
has been described in case reports. Most cases have in-
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Figure 2. 56-year-old man with Phaeoacremonium parasiti-
cum myositis. Intraoperative sonogram of the left thigh. 
Ellipsoid fluid collection with hyperechoic debris appears in 
the lateral thigh. Within the fluid collection, a linear hypere-
choic foreign body measuring about 0.5 x 0.2 x 0.1 cm 
(cross mark) appears.
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Figure 3. 56-year-old man with Phaeoacremonium parasiticum myositis. MRI of 
the left thigh with IV contrast obtained 3 months after surgical drainage. A. Axial 
T1-weighted MRI shows a nodular lesion of intermediate signal intensity (long 
white arrows) within the substance of the vastus lateralis muscle. B. Fat-
suppressed, T2-weighted MRI shows hyperintensity within the lesion, and a sur-
rounding rim of low signal intensity (short white arrows) that presumably repre-
sents infected granulation tissue. C. Axial, fat-suppressed, T1-weighted MRI fol-
lowing intravenous gadolinium-based contrast injection shows a nodular, some-
what serpinginous focus of enhancement within the vastus lateralis muscle (ar-
rowheads). There is enhancing edema in the surrounding vastus lateralis muscle. 
and no rim-enhancing abscess. D. Sagittal STIR MRI shows superficial and deep 
extension of the lesion, but the remaining muscles of the anterior compartment 
and the bone marrow are normal in signal.
Figure 4. 56-year-old man with Phaeoacremonium parasiticum myositis. Followup MRI of the left thigh with IV contrast 9 
months after surgical drainage. A. Axial, fat-suppressed, T2-weighted MRI shows hyperintensity lesion with surrounding 
edema in the vastus lateralis muscle that is decreased in size and intensity. There is a persistent low-signal-intensity rim (ar-
rows). B. Axial, fat-suppressed, T1-weighted MRI following intravenous gadolinium-based contrast injection shows small con-
glomerated enhancing lesion that is decreased in size. C. Sagittal STIR MRI shows resolved extension into the deep tissue.
 
volved immunocompromised patients; occasionally, fungal 
myositis has been reported in immunocompetent patients. 
The symptoms of  fungal myositis often overlap with that of 
bacterial myositis. A history of  severe immunosuppression 
and evidence of  other sites of  fungal infection may point to 
a fungal etiology (18). The most commonly reported cause 
of  fungal myositis is Candida spp. (19). Cryptococcus neoformans 
(20), Histoplasma capsulatum (21), Coccidioides spp. (22), Aspergil-
lus spp. (23), Pneumocystis jiroveci (24), and Fusarium spp. (25) 
have also been reported.
Reports on MRI findings of  fungal myositis are rare. 
Schwartz et al. (19) reported multimodality imaging of  the 
lower extremity in the case of  Candida tropicalis myositis and 
revealed changes in the muscles typical of  both myositis 
and solid-organ fungal disease. MRI demonstrated these 
findings best, with good visualization of  the numerous mi-
croabscesses, similar in appearance to the lesions seen in 
solid-organ fungal disease. Those microabscesses were su-
perimposed on a background of  diffuse muscular signal 
abnormality, consistent with inflammation. Our patient 
presented with a subcutaneous and intramuscular abscess 
demonstrated as a rim-enhancing lesion on postcontrast 
CT. After the surgery, initial followup MRI demonstrated a 
nodular, lobulated, and serpinginous enhancing lesion on 
top of  diffuse myositis. The lesion was considered to be 
granulation tissue, and it responded to antifungal treat-
ment. The low-signal-intensity rim observed in microab-
scesses of  Candida myositis also was observed in our case, 
mainly on the fluid-sensitive sequences. The significance of  
this low-signal-intensity rim related to fungal infection is 
uncertain, and further imaging and pathologic study is 
necessary.
The ideal treatment for P. parasiticum infection is not de-
fined, and the paucity of  cases does not allow for meaning-
ful comparisons of  antifungal agents. Agents commonly 
used in reported cases include amphotericin B preparations 
and azoles, but terbinafine and 5FC have also been admin-
istered (10, 11). In the case we report, the use of  posacona-
zole, a triazole antifungal agent, was empiric. Surgical 
debridement appears to be an important aspect of  the 
treatment of  localized P. parasiticum infection. However, 
wide excision of  the lesions has been recommended be-
cause of  the possibility of  relapse (3).
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